Trial · NCT04095104
Outcomes28
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 20 of 28
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Enrollment Rate | 6 months | percentage of participants | NUMBER | |
| PRIMARY | Dropout Rate | 24 months | percentage who withdrew among enrolled | NUMBER | |
| PRIMARY | Number of Participants Adherent to Study Drugs | 12 weeks | The one participant randomized to the placebo group who withdrew before taking a single dose of study medication was not included in this outcome. | Participants | COUNT_OF_PARTICIPANTS |
| PRIMARY | Frequency of Adverse Events | 24 months | The one participant randomized to the placebo group who withdrew before taking a single dose of study medication was not included in this outcome. | unique adverse events per participant | MEAN |
| SECONDARY | Percent BMI Change | Baseline and 12 weeks | percent change | MEAN | |
| SECONDARY | Percent Weight Change | Baseline and 12 weeks | percent change | MEAN | |
| SECONDARY | Change in BMI Percent of the 95th%Ile | Baseline and 12 weeks | For 1 member of the active group and 2 members of the placebo group, it was not appropriate to calculate a % above the 95th%ile either because BMI was \<95th%ile or they were \>19 completed years at the time point. | percentile change | MEAN |
| SECONDARY | Change in Heart Rate | Baseline and 12 weeks | beats per minute | MEAN | |
| SECONDARY | Change in Systolic Blood Pressure | Baseline and 12 weeks | mmHg | MEAN | |
| SECONDARY | Change in Diastolic Blood Pressure | Baseline and 12 weeks | mmHg | MEAN | |
| SECONDARY | Change in Total Cholesterol (mg/dL) | Baseline and 12 weeks | mg/dL | MEAN | |
| SECONDARY | Change in Triglycerides (mg/dL) | Baseline and 12 weeks | mg/dL | MEAN | |
| SECONDARY | Change in LDL Cholesterol (mg/dL) | Baseline and 12 weeks | mg/dL | MEAN | |
| SECONDARY | Change in HDL Cholesterol (mg/dL) | Baseline and 12 weeks | mg/dL | MEAN | |
| SECONDARY | Change in Alanine Aminotransferase (ALT) (U/L) | Baseline and 12 weeks | U/L | MEAN | |
| SECONDARY | Change in Hemoglobin A1c (HbA1c) (%) | Baseline and 12 weeks | Percentage of glycated hemoglobin | MEAN | |
| SECONDARY | Change in % Fat Mass | Baseline and 12 weeks | percentage of fat mass | MEAN | |
| SECONDARY | Change in Resting Metabolic Rate (RMR) | Baseline and 12 weeks | kilocalories per day | MEAN | |
| SECONDARY | Change in Daily Kilocalorie Intake | Baseline and 12 weeks | kilocalories | MEAN | |
| SECONDARY | Change in Hunger | Baseline and 12 weeks | VAS hunger ratings were missing from 1 participant in each the active and placebo groups | units on a scale | MEAN |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04095104/outcomes